Publication | Open Access
Systemic Human CR2-Targeted Complement Alternative Pathway Inhibitor Ameliorates Mouse Laser-Induced Choroidal Neovascularization
38
Citations
39
References
2012
Year
Systemic administration of TT30 was found to reduce CNV pathology. These data may open new avenues for novel systemic AMD treatment strategies.
| Year | Citations | |
|---|---|---|
Page 1
Page 1